Skip to Main Content
Center for Cancer ResearchCCR Home | About CCR | CCR Intranet

Headline Title

Neuro-Oncology
Select References
  1. Warren KE, Frank JA, Black JL, Hill RS, Duyn JH, Aikin AA, Lewis BK, Adamson PC, Balis FM. Prognostic Value of Proton Magnetic Resonance Spectroscopic Imaging in Children with Recurrent Primary Brain Tumors. J Clin Oncol  (2000) 18 (5): 1020-1026.

  2. Warren KE, McCully CM, Walsh TJ, Balis FM. Effect of Fluconazole on the Pharmacokinetics of Doxorubicin in Non-human Primates. Antimicrobial Agents Chemother (2000) 44: No. 4 1100-1101.

  3. Warren KE, Patel MC, Aikin AA, Libucha M, Adamson PC, Wideman B, Neuwirth R, Benziger D, O’Toole T, Ford K, Patronas N, Packer RJ, Balis FM. A Phase I Trial of Cereport® (RMP-7) and Carboplatin in Pediatric Patients with Brain Tumors. Cancer Chemother Pharmacol 48 (2001) 4, 275-282.

  4. Warren KE, N Patronas, A Aikin, P Albert, F Balis. Comparison of One Dimensional, Two Dimensional, and Three Dimensional Measurements of Brain Tumors in Pediatric Patients.  J Natl Cancer Inst (2001) 93(18): 1401-1405.

  5. Lutz RJ, Warren KE, Balis F, Patronas N, Dedrick RL.  Mixing during Intravertebral Infusions in an In Vitro Model.  J Neuro-Oncol  (2002) 58: 95-106.

  6. Warren KE, Anne Gervais, Alberta A. Aikin, Frank M. Balis.  Pharmacokinetics of Carboplatin When Administered with Lobradimil to Pediatric Patients with Brain Tumors Cancer Chemother Pharmacol (2004) 54: 206-212.

  7. Solomon J, Warren K, Dombi E, Patronas N, Balis F, Widemann B.  Automated Detection and Volume Measurement of Plexiform Neurofibromas in Neurofibromatosis 1 using Magnetic Resonance Imaging.  Computerized Medical Imaging and Graphics (2004) 28: 257-265.

  8. Packer RJ, Krailo M, Mehta M, Warren K, Allen J, Jakacki R, Villablanca J, Chiba A, Reaman G.  Phase 1 Study of Concurrent RMP-7 and Carboplatin with Radiation Therapy for Children with Newly Diagnosed Brainstem Gliomas. Cancer (2005); 104 (6):1281-7.

  9. Warren KE, Widemann BC, Fox E, Aikin AA, Libucha M, Packer RJ, Balis FM.  A Phase I Study of O6-Benzylguanine and Temozolomide in Pediatric Patients with Solid Tumors. J Clin Oncol (2005) 23 (30):7646-7653.

  10. Warren KE, Jakacki R, Widemann B, Aikin A, Libucha M, Packer R, Vezina G, Shaw D, Krailo M, Osborne C, Cehelsky J, Caldwell D, Nevius J, Steinberg S, Balis F.  A Phase II Trial of Intravenous Cereport® and Carboplatin in Pediatric Patients with Brain Tumors. Cancer Chemother Pharmacol  (2006) 58: 343-347.

  11. Lonser RR, Warren KE, Quezado Z, Butman, JA, Park DM, Walbridge S, Robison RA, Croteau D, Merrill M, Oldfield  EH. Real-time image-guided, direct convective perfusion of intrinsic  brainstem lesions. J Neurosurg (2007) 107:190-197.

  12. Steffen-Smith E, Wolters P, Albert P, Baker E, Shimoda K, Barnett A, Warren K.  “Detection and characterization of neurotoxicity in cancer patients using proton MR spectroscopy.” Childs Nervous Syst (2008) 24(7):807-13.

  13. Kim A, Fox E, Warren K, Blaney SM, Berg SL, Adamson PC, Libucha M, Byrley E, Balis FM, Steinberg SM, Widemann BC.  “Characteristics and outcome of pediatric patients enrolled on Phase I Oncology Trials” Oncologist (2008) 13(6): 679-89.

  14. Hayward RM, Patronas N, Baker EH, Vezina L-G, Albert PS, Warren KE. “Interobserver variability in the measurement of diffuse intrinsic pontine gliomas” J Neurooncol (2008) 90(1): 57-61.

  15. Meany HJ, Warren KE, Fox E, Cole DE, Aikin AA, Balis FM. “Pharmacokinetics of temozolomide administered in combination with O6-benzylguanine in children and adolescents with refractory solid tumors.” Cancer Chemother Pharmacol  2009 Dec; 65(1):137-42.

Dashed Line

return to the top

This Page Last Reviewed on February 26, 2013

About CCR | Clinical Trials | Research | Employment | Initiatives | News | Events | Site Privacy Policy | Accessibility

A Service of the National Cancer Institute

Department of Health and Human Services National Institutes of Health (NIH) USA Gov